Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
| Tick rows to compare them in a chart (up to 4) | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16.6 | 11.0 | 10.2 | 13.4 | – | – | – | – | – | – | – | – | – | – | – | |
| 15.1 | 17.6 | 15.0 | 11.7 | 14.2 | 11.4 | 6.0 | 8.8 | 8.5 | 11.2 | 5.2 | 5.6 | 8.8 | 7.0 | 9.4 | 5.6 | 8.9 | 6.3 | 17.6 | 17.4 | 25.8 | 33.3 | 51.7 | 25.6 | 16.9 | 14.6 | 11.6 | 10.9 | 13.5 | 51.5 | 52.0 | 68.7 | 92.0 | 66.1 | 82.1 | 104.9 | 95.6 | 155.1 | 135.7 | 38.6 | |
| 4.7 | 5.5 | 5.1 | 4.5 | 5.2 | 4.3 | 2.6 | 3.5 | 3.3 | 4.1 | 2.4 | 2.6 | 4.2 | 3.9 | 11.9 | 6.2 | 16.6 | 9.9 | 27.1 | 7.6 | 8.1 | 7.6 | 6.9 | 5.7 | 4.7 | 3.0 | 2.5 | 1.4 | 1.8 | 2.4 | 2.7 | 3.9 | 9.4 | 4.7 | 8.4 | – | – | 23.4 | 62.9 | 60.3 | |
| 14.3 | 17.3 | 14.7 | 11.4 | 13.9 | 11.2 | 5.7 | 8.3 | 8.1 | 11.7 | 5.9 | 6.4 | 10.0 | 8.4 | 11.1 | 7.5 | 11.0 | 8.2 | 18.8 | 19.4 | 28.6 | 38.0 | 62.0 | 35.7 | 27.0 | 14.3 | 13.1 | 11.1 | 12.8 | 50.2 | 51.0 | 65.8 | 90.2 | 60.1 | 74.8 | 103.7 | 92.7 | 167.7 | 142.4 | 41.4 | |
| 87.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.1% | -1.3% | -3.1% | -4.7% | -4.4% | -6.1% | -10.9% | -8.2% | -9.1% | -7.4% | -19.4% | -22.2% | -15.9% | -21.1% | -20.4% | -27.5% | -14.4% | -17.9% | -4.7% | -5.3% | -5.0% | -6.4% | -8.5% | -15.7% | -25.2% | -17.1% | -22.4% | -27.0% | -25.3% | -19.3% | -21.2% | -18.3% | -19.3% | -32.2% | -23.8% | -17.1% | -16.8% | -7.7% | -6.9% | -9.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 66.5% | 66.6% | 67.8% | 69.2% | 69.6% | 69.1% | 72.7% | 71.7% | 69.7% | 67.5% | 61.6% | 56.1% | 53.9% | 50.9% | 32.3% | 38.7% | 37.6% | 28.7% | 36.3% | 17.2% | 0.3% | 6.1% | -96.7% | -83.9% | -97.6% | -50.1% | -14.3% | 19.2% | 15.5% | 11.0% | -17.7% | -41.1% | -59.3% | -63.1% | -29.1% | -9.8% | -18.7% | 12.9% | 35.6% | 75.6% | |
| -55.6% | -68.1% | -65.6% | -57.7% | -63.0% | -71.9% | -59.6% | -70.0% | -79.9% | -96.3% | -304.4% | -354.8% | -370.1% | -383.6% | -225.1% | -166.7% | -148.9% | -120.3% | -46.4% | -83.0% | -155.8% | -256.3% | -715.5% | -561.5% | -581.0% | -262.9% | -281.4% | -331.4% | -334.8% | -1,291.9% | -1,428.5% | -1,652.1% | -2,952.4% | -3,277.9% | -3,440.3% | -3,171.0% | -2,399.5% | -1,860.2% | -1,141.1% | -297.2% | |
| -96.7% | -94.0% | -97.7% | -76.3% | -60.6% | -66.9% | -50.6% | -57.7% | -82.2% | -96.7% | -306.6% | -363.2% | -368.5% | -393.1% | -355.3% | -327.4% | -352.2% | -324.0% | -165.9% | -171.7% | -216.4% | -363.7% | -646.0% | -575.7% | -593.8% | 88.3% | 105.2% | 106.8% | 100.2% | -1,257.8% | -1,540.6% | -1,781.7% | -3,084.6% | -3,521.7% | -3,216.2% | -3,728.9% | -2,868.7% | -3,912.9% | -2,588.2% | -647.0% | |
| 17.4% | -22.8% | -45.9% | -55.0% | -63.0% | -69.2% | -65.2% | -72.5% | -77.3% | -83.1% | -100.7% | -124.7% | -139.5% | -147.8% | -191.6% | -154.2% | -129.1% | -112.2% | -81.9% | -92.5% | -128.2% | -212.6% | -441.7% | -403.7% | -426.0% | -249.3% | -260.0% | -293.2% | -340.4% | -992.7% | -1,099.9% | -1,256.9% | -1,775.5% | -2,127.1% | -1,955.6% | -1,791.5% | -1,607.7% | -1,198.6% | -933.8% | -372.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -29.8% | -29.2% | -33.3% | -29.1% | -22.4% | -25.1% | -21.9% | -23.1% | -31.7% | -35.6% | -139.2% | -167.4% | -178.1% | -216.1% | -449.5% | -364.9% | -651.7% | -510.2% | -254.9% | -75.4% | -68.2% | -82.9% | -85.9% | -127.4% | -164.7% | 17.9% | 22.4% | 13.5% | 13.3% | -57.6% | -80.9% | -99.9% | -313.6% | -252.0% | -327.8% | – | – | -589.6% | -1,198.6% | -1,010.2% | |
| -17.9% | -17.4% | -19.7% | -16.8% | -13.2% | -14.9% | -13.8% | -14.2% | -21.1% | -19.6% | -70.5% | -73.8% | -75.9% | -81.6% | -70.7% | -78.7% | -89.3% | -88.9% | -54.4% | -32.4% | -27.0% | -28.9% | -25.6% | -28.0% | -28.5% | 9.8% | 13.1% | 10.3% | 10.7% | -44.6% | -63.5% | -71.9% | -185.0% | -167.2% | -86.9% | -121.6% | -122.2% | -144.1% | -160.0% | -147.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -147 | -69 | -54 | -61 | -56 | -56 | -60 | -112 | -70 | 101 | 111 | 113 | 160 | 178 | 157 | 188 | 186 | 176 | 123 | 152 | 143 | 142 | 148 | 164 | 156 | -8.4 | 40 | 5.3 | -15 | -8.9 | -6.4 | -16 | -8.1 | -24 | -29 | -5.1 | -13 | 80 | 64 | 87 | |
| 60.1% | 59.7% | 59.0% | 57.7% | 59.0% | 59.4% | 63.0% | 61.8% | 66.6% | 55.0% | 50.7% | 44.1% | 42.6% | 37.8% | 15.7% | 21.6% | 13.7% | 17.4% | 21.4% | 42.9% | 39.5% | 34.8% | 29.8% | 22.0% | 17.3% | 55.0% | 58.5% | 76.2% | 80.1% | 77.4% | 78.5% | 71.9% | 59.0% | 66.3% | 26.5% | -10.9% | -36.1% | 24.4% | 13.4% | 14.6% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.6 | 0.7 | 0.8 | 1.0 | 3.1 | 2.6 | 4.7 | 3.5 | 2.6 | 1.0 | 1.1 | 1.4 | 1.7 | 2.8 | 3.6 | 0.6 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 2.2 | 4.5 | 4.7 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.56 | -1.48 | -1.57 | -1.29 | -1.03 | -1.11 | -0.97 | -1.00 | -1.35 | -1.48 | -3.84 | -3.43 | -3.23 | -3.19 | -2.08 | -1.99 | -1.97 | -1.80 | -0.96 | -0.68 | -0.55 | -0.55 | -0.46 | -0.47 | -0.46 | 0.13 | 0.14 | 0.11 | 0.09 | -0.34 | -0.39 | -0.39 | -0.54 | -0.51 | -0.43 | -0.53 | -0.42 | -0.83 | -0.80 | -0.65 | |
| 1.62 | 1.58 | 1.61 | 1.69 | 1.70 | 1.66 | 1.91 | 1.73 | 1.64 | 1.53 | 1.25 | 0.94 | 0.88 | 0.81 | 0.58 | 0.61 | 0.56 | 0.56 | 0.58 | 0.40 | 0.25 | 0.15 | 0.07 | 0.08 | 0.08 | 0.14 | 0.13 | 0.10 | 0.09 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.10 | |
| 5.24 | 5.07 | 4.72 | 4.44 | 4.60 | 4.43 | 4.42 | 4.33 | 4.25 | 4.16 | 2.76 | 2.05 | 1.82 | 1.48 | 0.46 | 0.54 | 0.30 | 0.35 | 0.38 | 0.90 | 0.80 | 0.66 | 0.54 | 0.37 | 0.28 | 0.71 | 0.61 | 0.80 | 0.67 | 0.59 | 0.48 | 0.39 | 0.17 | 0.20 | 0.13 | -0.05 | -0.12 | 0.14 | 0.07 | 0.06 | |
| 0.28 | -0.36 | -0.74 | -0.93 | -1.07 | -1.15 | -1.25 | -1.26 | -1.27 | -1.27 | -1.26 | -1.18 | -1.22 | -1.20 | -1.12 | -0.94 | -0.72 | -0.62 | -0.47 | -0.37 | -0.32 | -0.32 | -0.32 | -0.33 | -0.33 | -0.36 | -0.34 | -0.30 | -0.30 | -0.27 | -0.28 | -0.27 | -0.31 | -0.31 | -0.26 | -0.26 | -0.24 | -0.26 | -0.29 | -0.38 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.